Revelation Biosciences, Inc. (REVB) Total Assets by Year
Revelation Biosciences, Inc. closed fiscal year 2025 with $11.6M in total assets, $2.7M in total liabilities and $8.9M in shareholder equity. This represents an increase of 74.9% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Revelation Biosciences, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
REVB Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K |
|---|---|---|---|---|---|---|---|
| Total Assets | $11.6M+74.9% | $6.6M-45.8% | $12.2M+121.9% | $5.5M+169.5% | $2.0M-97.2% | $74.2M+327023.7% | $23K |
| Total Liabilities | $2.7M+42.2% | $1.9M-65.6% | $5.6M+25.0% | $4.5M+107.8% | $2.1M-97.0% | $70.8M+268821.6% | $26K |
| Total Equity | $8.9M+88.2% | $4.7M-29.2% | $6.6M+531.6% | $1.1M+1158.1% | -$99K-102.9% | $3.4M+93877.5% | -$4K |
REVB Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.5M+131.7% | $15.0M+278.9% | $11.6M+74.9% | $12.9M+90.7% | $5.4M-56.0% | $4.0M-73.0% | $6.6M-45.8% | $6.7M-52.6% | $12.3M-23.5% | $14.7M-18.9% | $12.2M+121.9% | $14.2M+115.4% |
| Total Liabilities | $2.4M+54.9% | $2.1M+88.6% | $2.7M+42.2% | $1.9M-54.4% | $1.6M-85.9% | $1.1M-79.2% | $1.9M-65.6% | $4.1M-24.7% | $11.1M+140.7% | $5.2M-35.5% | $5.6M+25.0% | $5.4M+23.5% |
| Total Equity | $10.1M+163.1% | $13.0M+350.9% | $8.9M+88.2% | $11.0M+311.5% | $3.8M+235.5% | $2.9M-69.6% | $4.7M-29.2% | $2.7M-69.7% | $1.1M-90.0% | $9.5M-5.4% | $6.6M+531.6% | $8.8M+295.9% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Revelation Biosciences, Inc. financials
Frequently Asked Questions
What was Revelation Biosciences, Inc.'s total assets in fiscal year 2025?
Revelation Biosciences, Inc. closed fiscal year 2025 with $11.6M in total assets, $2.7M in total liabilities and $8.9M in shareholder equity.
How fast is Revelation Biosciences, Inc.'s total assets growing?
Revelation Biosciences, Inc. (REVB) total assets rose by 74.9% year over year, from $6.6M to $11.6M in fiscal year 2025.
How has Revelation Biosciences, Inc.'s total assets changed over the years?
Across the 7 fiscal years this page covers, Revelation Biosciences, Inc. (REVB) total assets went from $23K in fiscal year 2019 to $11.6M in fiscal year 2025.
What was Revelation Biosciences, Inc.'s total assets in the most recent quarter?
Revelation Biosciences, Inc. (REVB) reported $12.5M in total assets in Q2 2026. This represents an increase of 131.7% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Revelation Biosciences, Inc. (REVB) reported on that line in every period on record.